Daniel Vitt - 26 Feb 2024 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Role: President and CEO, Director
Signature: /s/ Daniel Vitt
Issuer symbol: IMUX
Transactions as of: 26 Feb 2024
Net transactions value: +$18,333
Form type: 4
Filing time: 28 Feb 2024, 17:19:55 UTC
Previous filing: 19 Jan 2024
Next filing: 06 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMUX	Common Stock	Purchase	$18,333	+14,000	+3.7%	$1.31	390,877	26 Feb 2024	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	14,000 shares of Immunic, Inc. common stock are owned directly by the Reporting Person, and 362,877 shares of Immunic, Inc. common stock are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. The spouse of the Reporting Person acquired 14,000 shares of Immunic, Inc. common stock on February 26, 2024.

Content

14,000 shares of Immunic, Inc. common stock are owned directly by the Reporting Person, and 362,877 shares of Immunic, Inc. common stock are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. The spouse of the Reporting Person acquired 14,000 shares of Immunic, Inc. common stock on February 26, 2024.